MiR‐210‐3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5‐fluorouracil. Issue 12 (29th August 2019)

• Record Type: Journal Article
• Authors: Pranzini, Erica; Leo, Angela; Rapizzi, Elena; Ramazzotti, Matteo; Magherini, Francesca; Giovannelli, Lisa; Caselli, Anna; Cirri, Paolo; Taddei, Maria Letizia; Paoli, Paolo
• Is Part Of: Molecular carcinogenesis. Volume 58:Issue 12(2019)
• Page Start: 2181
• Page End: 2192
• Publication Date: 2019-08-29
• Subjects: chemoresistance -- DNA damage -- miR‐210‐3p -- oxidative phosphorylation -- 5‐fluorouracil; Carcinogenesis -- Molecular aspects -- Periodicals; 616.994071
• DOI: 10.1002/mc.23107
• Languages: English
• ISSNs: 0899-1987

Abstract

Abstract: Chemoresistance is the primary cause of chemotherapy failure. Compelling evidence shows that micro RNAs (miRNAs) contribute to reprogram cancer cells toward a resistant phenotype. We investigate the role of miRNAs in the response to acute treatment with 5‐FU in colon cancer‐resistant cells. We performed a global gene expression profile for the entire miRNA genome and found a change in the expression of four miRNAs following acute treatment with 5‐FU. Among them, we focused on miR‐210‐3p, previously described as a key regulator of DNA damage repair mechanisms and mitochondrial metabolism. We show that miR‐210‐3p downregulation enables resistant cells to counteract the toxic effect of the drug increasing the expression of RAD‐52 protein, responsible for DNA damage repair. Moreover, miR‐210‐3p downregulation enhances oxidative phosphorylation (OXPHOS), increasing the expression levels of succinate dehydrogenase subunits D, decreasing intracellular succinate levels and inhibiting HIF‐1α expression. Altogether, these adaptations lead to increased cells survival following drug exposure. These evidence suggest that miR‐210‐3p downregulation following 5‐FU sustains DNA damage repair and metabolic adaptation to counteract drug treatment.